跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT04383678
NCT04383678已完成不适用

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study

Helsinki University Central Hospital11 个研究点 分布在 6 个国家目标入组 132 人开始时间: 2020年3月1日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
132
试验地点
11
主要终点
In-hospital mortality
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.

详细描述

We evaluated the outcome of adult patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) requiring the use of extracorporeal membrane oxygenation (ECMO).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •PCR-confirmed or suspected COVID-19 infection with ARDS who require any ECMO therapy

排除标准

  • 未提供

结局指标

主要结局

In-hospital mortality

时间窗: Immediately after the intervention/procedure/surgery

All-cause mortality

次要结局

  • Death on ECMO(During the intervention/procedure/surgery)
  • Stroke(Immediately after the intervention/procedure/surgery)
  • Blood stream infection(Immediately after the intervention/procedure/surgery)
  • Lung complications requiring surgical treatment(Immediately after the intervention/procedure/surgery)
  • Blood transfusion(Immediately after the intervention/procedure/surgery)
  • Acute kidney injury(Immediately after the intervention/procedure/surgery)
  • Duration of mechanical ventilation(During index hospital stay follow-up until 1 year after ECMO initiation)
  • Deep vein thrombosis(Immediately after the intervention/procedure/surgery)
  • Pulmonary embolism(Immediately after the intervention/procedure/surgery)
  • Length of intensive care unit stay(Immediately after the intervention/procedure/surgery)
  • Length of hospital stay(Immediately after the intervention/procedure/surgery)
  • Death after hospital discharge(Up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fausto Biancari

Professor

Helsinki University Central Hospital

研究点 (11)

Loading locations...

相似试验

已完成
不适用
Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other EthiologiesARDSCOVID-19Influenza
NCT05353725University Medical Centre Ljubljana100
已完成
不适用
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19COVID-19
NCT05158816Jessa Hospital295
已完成
不适用
Extracorporeal Membrane Oxygenation Effect in Prolonged Cardiopulmonary ResuscitationCardiopulmonary ResuscitationVentricular FibrillationCardiac ArrestVentricular Tachycardia
NCT00173615National Taiwan University Hospital100
已完成
不适用
Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2Acute Refractory Heart Failure Related to SARS-CoV 2
NCT04397588Rennes University Hospital761
Unknown
不适用
Long-term Outcome of Patients Treated With Extracorporeal Membrane OxygenationLong-term OutcomeExtracorporeal Membrane Oxygenation
NCT03182023Southeast University, China83